Movement Disorders

The The Movement Disorders Program within the Neurology Clinic at UT Southwestern Medical Center is a major regional referral center for diagnosing and treating neurodegenerative disorders, such as Parkinson’s Disease. Since this program was developed more than 20 year ago, we’ve built an extraordinary level of expertise in pinpointing their underlying causes and providing comprehensive, individualized care to treat them.

Our Movement Disorders team handles more than 4,000 patient visits a year. This includes state-of-the-art care for:

Access to Innovative Therapies and Clinical Trials

As a world-class academic medical center, UT Southwestern offers patients with movement disorder unique access to research, clinical trials, and new therapies -- often before they’re available at other hospitals. Our Movement Disorders team has led extensive research programs to investigate the genetic and other contributing factors in the development of movement disorders. This includes a long-term National Institutes of Health (NIH)-funded trial for possible neuroprotective agents for Parkinson's disease.

Comprehensive Care for Patients

UT Southwestern’s Center for Movement Disorders has achieved success in treating a wide range involuntary, reduced, and/or slow movements. This includes help for patients experiencing trouble with walking and maintaining balance, standing up straight, toileting, the ability to speak, and other symptoms that result from their disease.

Because we offer a team approach to care, our patients have access to a full range of medical, surgical and support services. This includes neurologists who are fellowship-trained in movement disorders, neurosurgeons, advanced practice professionals, and the other health care professionals – all working together to coordinate treatment strategies and offer the best possible results for patients. We offer:

  • Guidance on medications, effective in treating movement disorders
  • Access to clinical research programs, which allow the possibility of exposure to investigational drugs before they are commercially available
  • Botulinum toxin treatments
  • Deep brain stimulation (DBS)
  • Physical, speech, and occupational therapy
  • Nutrition counseling
  • Mental health support
  • Information and support for family members